IMPPAT Phytochemical information: 
3',4'-Anhydrovinblastine

3',4'-Anhydrovinblastine
Clinical trials
Public title (as per ICTRP)Scientific title (as per ICTRP)Trial identifier
Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid TumorsPhase I Dose Finding Study of Anhydrovinblastine Administered as a 1-Hour Infusion Every 3 Weeks to Patients With Advanced Solid TumorsNCT00003882